NMRA — Neumora Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Dutch semis, Oracle, Ferguson Enterprises
J.P.Morgan downgrades Neumora, citing challenges in depression drug development
U.S. RESEARCH ROUNDUP- aTyr pharma, Clear Secure, Neumora Therapeutics
Neumora Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Neumora Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Neumora Therapeutics Inc On May 14, Receives Nasdaq Non-Compliance Notice
Neumora Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Neumora Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Mobileye, Visionary Holdings, Wolfspeed
U.S. STOCKS ON THE MOVE-Energy firms, Jazz Pharma, KLX Energy
Neumora falls as J&J's setback triggers concerns over depression drug
Neumora's IPO bookrunner Stifel cuts to 'hold' after J&J setback
Brief: Neumora Therapeutics Announces Leadership Transition
U.S. STOCKS ON THE MOVE-Tesla, Copper miners, Natgas firms
U.S. STOCKS ON THE MOVE-Tesla, Boeing, Gold miners
U.S. STOCKS ON THE MOVE-Tesla, Gold miners, VICI Properties
Neumora Therapeutics' depression drug fails to meet main goal of late-stage study (updated)
Neumora Therapeutics' depression drug fails to meet main goal of late-stage study
U.S. RESEARCH ROUNDUP-Cigna, Marriott, Ralph Lauren